The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too'' or "The Special One'' Antidiabetic Class?
AuthID
P-00G-AVS
P-00G-AVS
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service